Cann American Corp.

CNNA

US13764N2071

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 01:28:20 25/05/2024 am IST			5-day change	1st Jan Change
0.0033 ^USD	-5.71%		-17.50%	-17.50%

2023	Cann American Corp. Reports Earnings Results for the Full Year Ended February 28, 2023	CI
2023	Cann American Corp. Auditor Raises 'Going Concern' Doubt	CI

CANN AMERICAN CORP. : Changes in Registrant's Certifying Accountant, Change in Directors or Principal Officers (form 8-K)

October 25, 2022 at 12:30 am IST

Item 4.01 Changes in Registrant's Certifying Accountant.

On October 21, 2022, the Company dismissed Michael Gillespie & Associates, PLLC as the Company's auditor. The dismissal was not due to any dispute with the Company.

Item 5.02 Departure of Directors or Certain Officers;

On October 21, 2022, and effective on October 31, 2022, the Company accepted the resignation of Bradley Hanger as a Director of the Company. Mr. Hanger's resignation was not due to any dispute with the Company.

Latest news about Cann American Corp.

Cann American Corp. Reports Earnings Results for the Full Year Ended February 28, 2023	15/23/15	CI
Cann American Corp. Auditor Raises 'Going Concern' Doubt	14/23/14	CI
Cann American Corp. Appoints Michael G. Kramer as a Director	17/23/17	CI
Cann American Corp. completed the acquisition of acquire Liberty Health Plus.	10/23/10	CI
Cann American Corp. entered into a letter of intent to acquire Liberty Health Plus.	01/23/01	CI
Cann American Corp. Appoints Peter Caruso as Director	16/23/16	CI
Cann American Corp. acquired Prodigy Stem Cell, LLC.	16/23/16	CI
Cann American Corp. Announces Board and Executive Changes	06/23/06	CI
Cann American Corp. Announces CEO Changes	06/23/06	CI
Cann American Corp. Reinstates Jason Black as CEO	26/23/26	CI
Cann American Corp. Announces Executive Changes	26/23/26	CI
Cann American Corp. has entered into an additional binding letter of intent to acquire 75% equity in Valkyrie Systems Inc.	09/22/09	CI
Cann American Corp. Appoints Alexander Woods-Leo as CEO	02/22/02	CI
Cann American Corp. Announces Management Changes	02/22/02	CI
Cann American Corp. completed the acquisition of 80% stake in Mark2media Group LLC.	31/22/31	CI
Cann American Corp. entered into a binding letter of intent to acquire 80% stake in Mark2media Group LLC.	26/22/26	CI
Cann American Corp. Accepts the Resignation of Bradley Hanger as Director	25/22/25	CI
Cann American Corp. acquired Hourglass Enterprises LLC.	12/21/12	CI
Fly Beverage Corp. announced that it expects to receive funding from Cann American Corp.	04/20/04	CI
Canamed4Pets, Inc. will Change its Name to Cann American Corp	20/19/20	CI
Cann American Corp. entered into an agreement to acquire Cannequipt, LLC from Patrick King for $0.04 million.	21/19/21	CI
Bioflamex Corporation has Changed its Ticker to BFLXD from BFLX	04/14/04	CI
Bioflamex Corp. Introduces Emergency Escape System	10/13/10	CI
Terra Asset Management, Inc. cancelled the acquisition of Bioflamex Corporation in a reverse merger transaction.	17/12/17	CI
Bioflamex Corporation will Change its Ticker to BFLXE from BFLX	19/12/19	CI

Chart Cann American Corp.

Duration

Period

More charts

Company Profile

Cann American Corp. is a holding company. The Company is engaged in developing assets within the legal cannabis and hemp industries. The Company has two subsidiaries, Cannequipt, LLC and Hourglass Enterprises LLC. Cannequipt, LLC, intends to act as a research and development division. Hourglass Enterprises LLC, intends to focus on developing new assets in the state of Oklahoma. The Company primarily within the state of California.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CANN AMERICAN CORP.	-17.50%	25.82L
ELI LILLY AND COMPANY	+38.51%	73TCr
NOVO NORDISK A/S	+33.05%	60TCr
JOHNSON & JOHNSON	-6.23%	36TCr
MERCK & CO., INC.	+18.78%	33TCr
ABBVIE INC.	+1.35%	28TCr
ASTRAZENECA PLC	+16.00%	24TCr
NOVARTIS AG	+8.09%	21TCr
ROCHE HOLDING AG	-5.77%	21TCr
AMGEN INC.	+6.19%	16TCr